CoChat

Quantitation of small intestinal permeability during normal human drug absorption

Open access
Levitt, David G · 2013 · BMC Pharmacology and Toxicology

The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Understanding the quantitative relationship between a drug's physical chemical properties and its rate of intestinal absorption (QSAR) is critical for selecting candidate drugs. Because of limited experimental human small intestinal permeability data, approximate surrogates such as the fraction absorbed or Caco-2 permeability are used, both of which have limitations. METHODS: Given the blood concentration following an oral and intravenous dose, the time course of intestinal absorption in humans was determined by deconvolution and related to the intestinal permeability by the use of a new 3 parameter model function ("Averaged Model" (AM)). The theoretical validity of this AM model was evaluated by comparing it to the standard diffusion-convection model (DC). This analysis was applied to 90 drugs using previously published data. Only drugs that were administered in oral solution form to fasting subjects were considered so that the rate of gastric emptying was approximately known. All the calculations are carried out using the freely available routine PKQuest Java (http://www.pkquest.com) which has an easy to use, simple interface. RESULTS: Theoretically, the AM permeability provides an accurate estimate of the intestinal DC permeability for solutes whose absorption ranges from 1% to 99%. The experimental human AM permeabilities determined by deconvolution are similar to those determined by direct human jejunal perfusion. The small intestinal pH varies with position and the results are interpreted in terms of the pH dependent octanol partition. The permeability versus partition relations are presented separately for the uncharged, basic, acidic and charged solutes. The small uncharged solutes caffeine, acetaminophen and antipyrine have very high permeabilities (about 20 x 10-4 cm/sec) corresponding to an unstirred layer of only 45 μm. The weak acid aspirin also has a large AM permeability despite its low octanol partition at pH 7.4, suggesting that it is nearly completely absorbed in the first part of the intestine where the pH is about 5.4. CONCLUSIONS: The AM deconvolution method provides an accurate estimate of the human intestinal permeability. The results for these 90 drugs should provide a useful benchmark for evaluating QSAR models.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2050-6511-14-34

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 AM model deconvolution solution for intestinal absorption of acetaminophen. Figure 1A shows a comparison of the experimental blood concentration data points (red circles) following an IV input versus the theoretical blood concentration determined from the 2 exponential systemic response function (line). Figure 1B shows a comparison of the experimental blood concentration data points (red circles) following an oral input with the theoretical blood concentration prediction determined from the deconvolution solution of the AM absorption rate function. Figure 1C shows the cumulative AM absorption amount as a function of time.
Figure 1 AM model deconvolution solution for intestinal absorption of acetaminophen. Figure 1A shows a comparison of the experimental blood concentration data points (red circles) following an IV input versus the theoretical blood concentration determined from the 2 exponential systemic response function (line). Figure 1B shows a comparison of the experimental blood concentration data points (red circles) following an oral input with the theoretical blood concentration prediction determined from the deconvolution solution of the AM absorption rate function. Figure 1C shows the cumulative AM absorption amount as a function of time.CC BY · PubMed Central
Figure 2 AM model deconvolution solution for intestinal absorption of risedronate. See Figure 1 for details.
Figure 2 AM model deconvolution solution for intestinal absorption of risedronate. See Figure 1 for details.CC BY · PubMed Central
Figure 3 AM model deconvolution solution for intestinal absorption of cimetidine. Figure 3A shows a comparison of the experimental blood concentration data points (red circles) following an oral input versus the theoretical blood concentration prediction determined from the deconvolution solution of the AM absorption rate function. Figure 3B shows the cumulative AM absorption amount as a function of time.
Figure 3 AM model deconvolution solution for intestinal absorption of cimetidine. Figure 3A shows a comparison of the experimental blood concentration data points (red circles) following an oral input versus the theoretical blood concentration prediction determined from the deconvolution solution of the AM absorption rate function. Figure 3B shows the cumulative AM absorption amount as a function of time.CC BY · PubMed Central
Figure 4 AM model deconvolution solution for intestinal absorption of acetylcysteine. Figure 4A shows a comparison of the experimental blood concentration data points (red circles) following an oral input versus the theoretical blood concentration prediction determined from the deconvolution solution of the AM absorption rate function. Figure 4B shows the cumulative AM absorption amount as a function of time.
Figure 4 AM model deconvolution solution for intestinal absorption of acetylcysteine. Figure 4A shows a comparison of the experimental blood concentration data points (red circles) following an oral input versus the theoretical blood concentration prediction determined from the deconvolution solution of the AM absorption rate function. Figure 4B shows the cumulative AM absorption amount as a function of time.CC BY · PubMed Central
Figure 5 Diffusion convection concentration profile. The diffusion convection model concentration as a function of distance from the pyloric sphincter is shown at 20 (Figure 5A), 100 (B) and 300 minutes (C) after administering the oral dose as a bolus to the stomach for an impermeable (P = 0) solute. The profile is shown for 4 different values of the dispersion time constant (TD): 2000 (red); 1000 (blue); 200 (green); and 20 minutes (black). For all profiles TF = 200 minutes; TG = 15 minutes; r = 1 cm; L = 600 cm and Dose = 1.
Figure 5 Diffusion convection concentration profile. The diffusion convection model concentration as a function of distance from the pyloric sphincter is shown at 20 (Figure 5A), 100 (B) and 300 minutes (C) after administering the oral dose as a bolus to the stomach for an impermeable (P = 0) solute. The profile is shown for 4 different values of the dispersion time constant (TD): 2000 (red); 1000 (blue); 200 (green); and 20 minutes (black). For all profiles TF = 200 minutes; TG = 15 minutes; r = 1 cm; L = 600 cm and Dose = 1.CC BY · PubMed Central
Figure 6 Diffusion convection small intestinal transit time. The diffusion convection amount leaving the small intestine and entering the large intestine as a function of time for an impermeable solute. Same conditions as for Figure 5.
Figure 6 Diffusion convection small intestinal transit time. The diffusion convection amount leaving the small intestine and entering the large intestine as a function of time for an impermeable solute. Same conditions as for Figure 5.CC BY · PubMed Central
Figure 7 Permeability dependence of the diffusion convection intestinal absorption. The fractional absorption of the diffusion convection model as a function of the permeability in units of 10-4 cm/sec for a dispersion time constant (TD) of 1000 (blue) or 200 minutes (green). The rest of the conditions are the same as in Figure 5.
Figure 7 Permeability dependence of the diffusion convection intestinal absorption. The fractional absorption of the diffusion convection model as a function of the permeability in units of 10-4 cm/sec for a dispersion time constant (TD) of 1000 (blue) or 200 minutes (green). The rest of the conditions are the same as in Figure 5.CC BY · PubMed Central
Figure 8 Comparison of intestinal absorption rate for DC and AM models with TD = 200 minutes. The DC model rate of absorption (red) was generated for a high permeability solute (P = 4.17 x 10-4 cm/sec, Figure 8A) and a low permeability solute (P = 0.00417 x 10-4 cm/sec, Figure 8B) with the rest of conditions the same as in Figure 5. Then the AM model parameters that provided the best fit to the DC model were determined and the AM absorption rate (blue) plotted. See Table 1 for tabulation of the AM parameters.
Figure 8 Comparison of intestinal absorption rate for DC and AM models with TD = 200 minutes. The DC model rate of absorption (red) was generated for a high permeability solute (P = 4.17 x 10-4 cm/sec, Figure 8A) and a low permeability solute (P = 0.00417 x 10-4 cm/sec, Figure 8B) with the rest of conditions the same as in Figure 5. Then the AM model parameters that provided the best fit to the DC model were determined and the AM absorption rate (blue) plotted. See Table 1 for tabulation of the AM parameters.CC BY · PubMed Central
Figure 9 Comparison of intestinal absorption rate for DC and AM models with TD = 1000 minutes. See Figure 8 for details.
Figure 9 Comparison of intestinal absorption rate for DC and AM models with TD = 1000 minutes. See Figure 8 for details.CC BY · PubMed Central
Figure 10 Permeability versus octanol partition for neutral solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the neutral solutes in Additional file 1: Table 2. The colored points indicate solutes which may have protein mediated transport: Red = xylose (glucose transport system); Green = digoxin, β-methyl digoxin and colchicine (P-glycloprotein mediated efflux); Blue = lamivudine (organic cation transporter). The solid line is the linear regression fit to the black points.
Figure 10 Permeability versus octanol partition for neutral solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the neutral solutes in Additional file 1: Table 2. The colored points indicate solutes which may have protein mediated transport: Red = xylose (glucose transport system); Green = digoxin, β-methyl digoxin and colchicine (P-glycloprotein mediated efflux); Blue = lamivudine (organic cation transporter). The solid line is the linear regression fit to the black points.CC BY · PubMed Central
Figure 11 Permeability versus octanol partition for basic solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the basic solutes in Additional file 1: Table 2. The log D was determined at pH = 7.4 (Figure 11A), 6.4 (Figure 11B) and 5.4 (Figure 11C). The solid line is the linear regression fit to the black points and the dashed line is the linear regression fit to the neutral solutes (Figure 10). The orange point is midodrine which is a substrate for the peptide transport system.
Figure 11 Permeability versus octanol partition for basic solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the basic solutes in Additional file 1: Table 2. The log D was determined at pH = 7.4 (Figure 11A), 6.4 (Figure 11B) and 5.4 (Figure 11C). The solid line is the linear regression fit to the black points and the dashed line is the linear regression fit to the neutral solutes (Figure 10). The orange point is midodrine which is a substrate for the peptide transport system.CC BY · PubMed Central
Figure 12 Permeability versus octanol partition for acidic solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the acidic solutes in Additional file 1: Table 2. The log D was determined at pH = 7.4 (Figure 12A), 6.4 (Figure 12B) and 5.4 (Figure 12C). The solid line is the linear regression fit to the black points and the dashed line is the linear regression fit to the neutral solutes (Figure 10).
Figure 12 Permeability versus octanol partition for acidic solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the acidic solutes in Additional file 1: Table 2. The log D was determined at pH = 7.4 (Figure 12A), 6.4 (Figure 12B) and 5.4 (Figure 12C). The solid line is the linear regression fit to the black points and the dashed line is the linear regression fit to the neutral solutes (Figure 10).CC BY · PubMed Central
Figure 13 Permeability versus octanol partition for charged solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the charged solutes in Additional file 1: Table 2. The solid line is the linear regression fit to the black points and the dashed line is the linear regression fit to the neutral solutes (Figure 10). The green points are cefixime and aztreonam which are substrate for the P-glycloprotein mediated efflux system.
Figure 13 Permeability versus octanol partition for charged solutes. Plot of the log of the permeability (cm/sec) versus the log of the octanol/water partition (log D) for the charged solutes in Additional file 1: Table 2. The solid line is the linear regression fit to the black points and the dashed line is the linear regression fit to the neutral solutes (Figure 10). The green points are cefixime and aztreonam which are substrate for the P-glycloprotein mediated efflux system.CC BY · PubMed Central
Figure 14 Comparison of the AM versus the human jejunal perfusion permeability. Plot of the log of the jejunal permeability (cm/sec) versus the log of the AM permeabililty (Additional file 1: Table 2). The dashed line is the line of identity. The red point is the weak acid furosemide and the green point is the uncharged antipyrine.
Figure 14 Comparison of the AM versus the human jejunal perfusion permeability. Plot of the log of the jejunal permeability (cm/sec) versus the log of the AM permeabililty (Additional file 1: Table 2). The dashed line is the line of identity. The red point is the weak acid furosemide and the green point is the uncharged antipyrine.CC BY · PubMed Central
Figure 15 Comparison of the AM versus the Caco-2 permeability. Plot of the log Caco-2 permeability (cm/sec) versus the log of the AM permeability (Additional file 1: Table 2). The points are colored on the basis of their charge state: Black = basic, Red = acidic, Green = uncharged, Blue = charged. The solid line is the linear regression fit to all the points.
Figure 15 Comparison of the AM versus the Caco-2 permeability. Plot of the log Caco-2 permeability (cm/sec) versus the log of the AM permeability (Additional file 1: Table 2). The points are colored on the basis of their charge state: Black = basic, Red = acidic, Green = uncharged, Blue = charged. The solid line is the linear regression fit to all the points.CC BY · PubMed Central
Figure 16 AM fraction absorbed versus AM permeability. Plot of the AM fraction absorbed versus the log of the AM permeability (cm/sec). The points are colored on the basis of their charge state: Black = basic, Red = acidic, Green = uncharged, Blue = charged.
Figure 16 AM fraction absorbed versus AM permeability. Plot of the AM fraction absorbed versus the log of the AM permeability (cm/sec). The points are colored on the basis of their charge state: Black = basic, Red = acidic, Green = uncharged, Blue = charged.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 2

  1. Gray VA Dressman JB Change of pH requirement for simulated intestinal fluid TS Pharmacopeial Forum 1996 22 1 1943 1945
  2. Lalezari D Gastrointestinal pH profile in subjects with irritible syndrome Ann Gastroenterol 2012 25 4 1 524713794

Cited by

See all 34

Metadata

Authors
Levitt, D. G.
Affiliations
University of Minnesota (US)
Corresponding author
Levitt, David G
Venue
BMC Pharmacology and Toxicology
Published
2013-06-24
Volume
14
Issue
1
Pages
34-34
ISSN
2050-6511 (ISSN-L)
OpenAlex
W2046132328
Cited by
32
References
66
Citations by year
2026: 4 · 2024: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 4
FWCI
2.01
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • BMC Pharmacology and Toxicology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
intestinal permeability, small intestinal absorption, drug absorption, deconvolution, averaged model, convection-diffusion model, QSAR, intestinal pH, unstirred layer, caffeine, paracetamol, antipyrine, aspirin
MeSH terms
Absorption, Pharmaceutical Preparations, Humans, Intestinal Absorption, Intestine, Small, Models, Biological, Permeability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quantitation of small intestinal permeability during normal human drug absorption. https://app.cochat.ai/papers/10.1186/2050-6511-14-34
The paper
Levitt, D. G. (2013). Quantitation of small intestinal permeability during normal human drug absorption. BMC Pharmacology and Toxicology. https://doi.org/10.1186/2050-6511-14-34

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.